Amgen News

This is a continuation of my previous article on biotechnology stocks to watch ahead of ASCO 2012.

Amgen, the world's largest biotechnology company, continues to lead the payrolls of the most well-compensated executives in the region's public companies, with its top three bosses earning a combined $31.7 million last year.

This is a continuation of my previous article on biotechnology stocks to watch ahead of ASCO 2012.

THOUSAND OAKS, Calif., May 23, 2012 /PRNewswire/ -- Amgen today announced voting results from the Company's Annual Meeting of Stockholders, held at the Four Seasons Hotel, Westlake Village, Calif.

Germany's central bank says the 17-country eurozone would be able to cope with Greece failing to implement austerity and reform promises.

Rose Delfino signs a petition while protesting outside the Amgen Inc. stockholders meeting Wednesday at the Four Seasons Hotel in Westlake Village.

Biotech drugmaker Amgen Inc. has introduced new CEO Bob Bradway to shareholders at the company's annual meeting, with retiring CEO Kevin Sharer stepping down after a decade.

By The Associated Press LATE DAY CHANGE: A big final-hour comeback pulled the Dow Jones industrial average nearly back to where it started Wednesday.

It was just a day ago that I wrote, in reference to Agilent 's probable M&A strategy, "I would be surprised if the company targeted sequencing or diagnostics." Well, color me surprised, as Agilent announced on the morning of May 17 that it will be acquiring Danish oncology diagnostic company Dako for $2.2 billion in cash.

Medgenics scores again. After a season of good news, the company recently told investors that in record time, the FDA approved its filing to start clinical trials using its Biopump platform technology to treat anemia in kidney dialysis patients.

Dachshund mix Phoenix and pit-bull mix Natalia have been undergoing treatment at the Pet Emergency Clinics and Specialty Hospital in Thousand Oaks with help from the Grossman Burn Center at West Hills Hospital.

Tom Berube, who rides his bike from Simi Valley to Amgen, where he works, stops to speak with Kathy Lowry, city of Thousand Oaks bike coordinator, who gives him food and a bag of free bike goods Friday as part of the National Bike to Work Day in Thousand Oaks.

Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing.

In the news release, Amgen's BiTE Antibody Blinatumomab Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, issued by Amgen over PR Newswire, we are advised by the company that the third paragraph now includes additional safety information.

Incoming Amgen chief Robert Bradway takes the baton from longtime CEO Kevin Sharer as the world's largest biotech company makes critical decisions about how it will compete with Big Pharma and biosimilars.

Very few sectors have been able to avoid the sell-off in May. The strongest of the group has been the biotech stocks, which measured by the Dow Jones Biotechnology Index, is at an all-time high.

Amgen's BiTEA Antibody Blinatumomab Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia THOUSAND OAKS, Calif., May 16, 2012 /PRNewswire/ -- Amgen today announced updated results from a Phase 2 study that showed treatment with blinatumomab helped achieve a high-rate of complete response ... (more)

Amgen's BiTE? Antibody Blinatumomab Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Greater than 70 Percent of Patients in the Study Achieved Complete Response Median Survival 9.0 Months, with a Median Follow-up of 10.7 Months Amgen's BiTE Antibody Blinatumomab Achieved High Rate of ... (more)

Amgen Inc. 's experimental drug rilotumumab, almost shelved by the company after it disappointed in a study, has been revived after a closer look at data in a gastric cancer trial found it helped a group of patients.

Healthcare costs have been on the rise. Annual medical costs increased almost 35% from 2006 to 2010, with healthcare spending rising 8% a year .